Abstract |
We evaluated racemic zopiclone, its (S)- and (R)-enantiomers and a metabolite, (S)- desmethylzopiclone, for their actions on locomotor activity, rotarod performance, the elevated plus maze and the Vogel conflict test of anxiety, and electroconvulsive shock-induced seizures duration. Zopiclone and its (R)- and (S)-enantiomers reduced locomotor activity, and zopiclone and its (S)-enantiomer disrupted rotarod performance at 10 mg/kg. (S)- desmethylzopiclone did not alter these measures at doses of less than 200 mg/kg. (S)- desmethylzopiclone altered plus maze performance at the lowest dose of all the zopiclone derivatives tested, caused a dose-related effect on the Vogel conflict test and caused a dose-related reduction of electroconvulsive shock-induced seizure durations. The data indicate that (S)- desmethylzopiclone can bring about an anxiolytic effect without a substantial degree of central nervous system depression, and suggest that the agent may be particularly useful clinically in the treatment of anxiety.
|
Authors | J N Carlson, R Haskew, J Wacker, I M Maisonneuve, S D Glick, T P Jerussi |
Journal | European journal of pharmacology
(Eur J Pharmacol)
Vol. 415
Issue 2-3
Pg. 181-9
(Mar 2001)
ISSN: 0014-2999 [Print] Netherlands |
PMID | 11274997
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Anxiety Agents
- Anticonvulsants
- Azabicyclo Compounds
- Hypnotics and Sedatives
- Piperazines
- zopiclone
- N-desmethylzopiclone
- Diazepam
- Alprazolam
|
Topics |
- Alprazolam
(pharmacology)
- Animals
- Anti-Anxiety Agents
(pharmacology, therapeutic use)
- Anticonvulsants
(pharmacology, therapeutic use)
- Anxiety
(drug therapy)
- Azabicyclo Compounds
- Diazepam
(pharmacology)
- Dose-Response Relationship, Drug
- Electroshock
- Hypnotics and Sedatives
(pharmacology, therapeutic use)
- Isomerism
- Male
- Motor Activity
(drug effects, physiology)
- Motor Skills
(drug effects, physiology)
- Piperazines
(chemistry, pharmacology, therapeutic use)
- Rats
- Rats, Long-Evans
- Seizures
(drug therapy)
|